SHARLENE QUARLESS: Open Payments
NPI 1881816825 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 16 payments from 8 companies in 2025. Trend: 2023 $700 · 2024 $583 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $119 |
| PFIZER INC. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: REPATHA, ELIQUIS, JARDIANCE, VERQUVO, OPSUMIT, Kerendia, LEQVIO, LifeVest.
Industry payments across GA — which companies pay providers there.
